Bowen Hanes & Co. Inc. Has $6.78 Million Stake in Xylem Inc. $XYL

Bowen Hanes & Co. Inc. lowered its stake in shares of Xylem Inc. (NYSE:XYL) by 14.5% during the first quarter, Holdings Channel.com reports. The institutional investor owned 56,772 shares of the industrial products company’s stock after selling 9,655 shares during the quarter. Bowen Hanes & Co. Inc.’s holdings in Xylem were worth $6,784,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Wexford Capital LP acquired a new stake in Xylem in the third quarter worth $27,000. Commonwealth Retirement Investments LLC bought a new stake in shares of Xylem in the 4th quarter valued at $27,000. Global Assets Advisory LLC bought a new stake in shares of Xylem in the 1st quarter valued at $40,000. FWL Investment Management LLC acquired a new stake in Xylem during the 2nd quarter worth $43,000. Finally, Entrust Financial LLC bought a new position in Xylem during the fourth quarter worth about $45,000. 87.96% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Stifel Nicolaus decreased their target price on Xylem from $159.00 to $157.00 and set a “buy” rating for the company in a research note on Monday. Jefferies Financial Group upgraded Xylem from a “hold” rating to a “buy” rating and lifted their price objective for the company from $130.00 to $140.00 in a report on Thursday, June 25th. Citigroup decreased their price objective on Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Weiss Ratings cut Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Finally, Barclays dropped their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a report on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, Xylem presently has an average rating of “Moderate Buy” and an average price target of $153.15.

Xylem Stock Up 0.7%

XYL stock opened at $117.00 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. The stock has a market capitalization of $27.81 billion, a P/E ratio of 29.11, a P/E/G ratio of 1.65 and a beta of 1.03. Xylem Inc. has a fifty-two week low of $105.29 and a fifty-two week high of $154.27. The business has a 50-day moving average of $113.81 and a 200-day moving average of $122.84.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. The business had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.Xylem’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, sell-side analysts anticipate that Xylem Inc. will post 5.52 earnings per share for the current fiscal year.

Xylem Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were issued a $0.43 dividend. The ex-dividend date was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. Xylem’s dividend payout ratio (DPR) is 42.79%.

Insider Buying and Selling

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jerome A. Peribere bought 1,210 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The stock was acquired at an average cost of $116.61 per share, with a total value of $141,098.10. Following the transaction, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This represents a 4.65% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.32% of the stock is owned by company insiders.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.